Product NDC: | 60505-2648 |
Proprietary Name: | Tizanidine Hydrochloride |
Non Proprietary Name: | Tizanidine Hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; Tizanidine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2648 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078868 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120206 |
Package NDC: | 60505-2648-0 |
Package Description: | 10 BLISTER PACK in 1 CARTON (60505-2648-0) > 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK |
NDC Code | 60505-2648-0 |
Proprietary Name | Tizanidine Hydrochloride |
Package Description | 10 BLISTER PACK in 1 CARTON (60505-2648-0) > 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK |
Product NDC | 60505-2648 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tizanidine Hydrochloride |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20120206 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | TIZANIDINE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |